CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 6696 | 7934 | 84.4% | |
| CKD 4 | 2008 | 7730 | 9233 | 83.7% | |
| CKD 5 | 2009 | 1403 | 1574 | 89.1% | |
| CKD 5 | 2010 | 784 | 866 | 90.5% | |
| CKD 5 | 2011 | 913 | 1012 | 90.2% | |
| CKD 5 | 2012 | 933 | 1033 | 90.3% | |
| CKD 5 | 2013 | 941 | 1056 | 89.1% | |
| CKD003 | 2014 | 847 | 946 | 89.5% | |
| CKD003 | 2015 | 804 | 896 | 89.7% | |
| CKD003 | 2016 | 731 | 817 | 89.5% |
